Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction

Published:2021-02 Issue: Volume:140 Page:25-32
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Tomasik Andrzej,Nabrdalik Katarzyna^ORCID,Kwiendacz Hanna,Radzik Edyta,Pigoń Katarzyna,Młyńczak Tomasz,Sawczyn Tomasz^ORCID,Gumprecht Janusz,Nowalany-Kozielska Ewa,Lip Gregory Y.H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045;Cho;Diabetes Res Clin Pract,2018

2. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries;Ambrosy;J Am Coll Cardiol,2014

3. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors;Nichols;Diabetes care,2001

4. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial;Sarma;Eur J Heart Fail,2013

5. Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies;Tarvasmäki;Eur Heart J Acute Cardiovasc Care,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research status and development trends of post-myocardial infarction heart failure: a bibliometric analysis from 2012 to 2022;2024-01-22

2. Effects of Tirofiban in Patients with Acute Myocardial Infarction and Diabetes Mellitus undergoing Primary Percutaneous Coronary Intervention;Current Vascular Pharmacology;2024-01

3. Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status;Scientific Reports;2023-01-05

4. Wykorzystanie baz danych Narodowego Funduszu Zdrowia przy ocenie dowodów naukowych z praktyki klinicznej;Zdrowie Publiczne i Zarządzanie;2022-11-30

5. Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry);Journal of Clinical Medicine;2022-10-25